DANONE : 2013 First-Quarter Sales

Tue Apr 16, 2013 1:32am EDT

* Reuters is not responsible for the content in this press release.

For best results when printing this announcement, please click on the link below:


------------ PRESS RELEASE ------------



2013 First-Quarter Sales

April 16, 2013

Solid start to the year: 
organic growth +5.6% in the first quarter

Full-year targets for 2013 confirmed

*Q1 2013 sales[1], up +5.6% like-for-like[3], and up +4.3% as reported, with balanced increases in
volume (+3.0%)[2] and value (+2.6%)[2] 
*As anticipated, performance varied from region to region: sales grew by over +10%[2] in emerging
markets and North America combined, with the accelerating Q1 trend driven by exceptionally strong
growth in Baby Nutrition. At the same time, sales in Europe fell back -5.1%[2], a trend comparable
to that observed in Q4 2012 
*Danone confirms its full-year targets for 2013: sales[1] growth of at least +5%[2], trading
operating margin down, by between -50 bps and -30 bps[2], and free cash-flow[3] held steady of
around EUR2 billion excluding exceptional items[3] 

[1] Net sales
[2] Like-for-like (see definition page 7) 
[3] See page 7 for details on calculation of financial indicators not defined in IFRS


Chairman's comment

"As we expected, the first quarter of 2013 saw a solid performance that highlighted once again the
contrast between robust growth in emerging markets and the sluggish economy in Europe.

In both Russia and the United States our brands scored further strong gains, underpinned by our
ongoing efforts to innovate and drive category growth. In Asia growth reached record highs,
particularly in Baby Nutrition. Sales continued to grow steadily in both Latin America and Africa,
benefiting fully from the emergence of a middle class.

In Europe consumer spending is still lackluster, especially in Fresh Dairy Products. Our teams are
fully engaged, taking action to innovate and update our product ranges. The cost reduction and
organizational adaptation plan we presented in February is moving ahead on schedule, and
consultations with employee representatives are now under way. Initial results of all these
measures are expected in the second half of the year.

Results to date are in line with our roadmap and reflect progress in building a profitable growth
model. On this basis, we stand by our full-year targets for 2013."

Sales by business line and geographical area in Q1 2013

 By business line (EUR millions)  Q1 12  Q1 13  Change[1]  Volume growth [1]  
 BY BUSINESS LINE                                                             
 Fresh Dairy Products             2 960  2 952    +0.7%          +0.5%        
 Waters                            841    887     +8.6%          +4.6%        
 Baby Nutrition                   1 014  1 177    +17.1%         +7.8%        
 Medical Nutrition                 302    322     +6.3%          +6.2%        
 BY GEOGRAPHICAL AREA                                                         
 Europe excl. CIS                 2 116  2 005    -5.1%          -3.8%        
 CIS & North America[2]           1 084  1 163    +8.5%          +4.9%        
 ALMA[3]                          1 917  2 170    +16.6%         +8.2%        
 Group                            5 117  5 338    +5.6%          +3.0%        

[1] Like-for-like; see page 7 for details on calculation of financial indicators not defined in
   [2] North America: United States and Canada
   [3] Asia-Pacific / Latin America / Middle East / Africa

Overview of sales performance - Q1 2013

Consolidated sales rose +4.3% to EUR5,338 million in the first quarter of 2013. Excluding the
impact of changes in the basis for comparison, which include exchange rates and scope of
consolidation, sales were up +5.6%. This organic growth reflects a +3.0% increase in sales volume
and a +2.6% increase in value. 

The exchange-rate effect of -2.4% reflects unfavorable trends in the Argentinian peso, the
Brazilian real, the Indonesian rupee and other currencies. Changes in the scope of consolidation
led to a +1.2% rise in sales, that primarily reflected the integration of Centrale Laitière
(Morocco) from March 2013.

Fresh Dairy Products

Fresh Dairy Products division sales were up +0.7% like-for-like in the first quarter of 2013,
including a +0.5% rise in volume and a +0.2% price/mix effect. This reflects similar trends
observed in the previous quarter, scaled back by one less day this quarter than in the first three
months of 2012.

Sales in the CIS and North America[1] region have continued the pace of growth observed at the end
of 2012 and are in line with expectations for full-year 2013. In North America, momentum is still
driven by market share gains in the Greek yogurt segment, where additional capacity will be added
in the short term to meet strong demand.

Sales in Latin America and the Africa-Middle East region remained extremely buoyant, with
continued double-digit growth.

Conditions in Europe have remained difficult with Q1 trends similar to those observed in the last
quarter of 2012. That includes a negative price/mix effect resulting notably from investments in
pricing and promotion.

[1] North America: United States and Canada


The Waters division once again reported solid growth in sales, up +8.6% like-for-like from Q1
2012. Gains were balanced with sales volume up +4.6% and value up +4.0%, reflecting the positive
price/mix effect of growth in aquadrinks in particular. 

Vigorous growth in emerging countries continued to drive the division. In Europe, sales edged
down, hit by the cold wave in March.

Baby Nutrition

The Baby Nutrition division reported exceptional sales in Q1 2013 with a like-for-like rise of

Momentum came once again from booming sales in the Asia-Pacific region, especially China this
quarter, also boosted by the Chinese New Year which came later than in 2012. Surging growth in
Europe was linked to the appeal of international baby formula brands for consumers in some
emerging countries.

As in the past, changes in the division's product mix made a positive contribution to performance:
the growing-up milk segment again reported double-digit growth and weaning foods continued to lose
ground in Europe.

Medical Nutrition

Medical Nutrition division sales rose +6.3% like-for-like in Q1 2013, driven by a volume rise of

Growth was again moderate in Europe, with contrasts from one country to the next. Emerging markets
continued to gain momentum within the division, reflecting successful growth in flagship markets
such as China, Turkey and Brazil, but also the emergence of new markets such as Russia, Poland and

Transactions linked to the share capital of Danone and its subsidiaries

On February 28, 2013, Danone finalized share buybacks mentioned in the press release issued on
October 17, 2012, which announced that a total budget of EUR500-700 million was earmarked for
buybacks. Between these two dates, the Group thus purchased 14.1 million shares for a total EUR700

In addition, as announced when full-year 2012 results were released, Danone has bought back 6.7
million of its own shares since early March to replace treasury shares used to pay minority
shareholders for their sale of shareholdings in Danone Spain in early 2013, and thus eliminate
dilution resulting from that transaction. 

As also indicated in February 2013, in the opening months of 2013 Danone finalized discussions
with certain minority shareholders of Danone Spain and raised its equity interest in this
subsidiary to 75%. Conditions applied took into account trends on markets in which Danone Spain
operates, the impact of deterioration in the Spanish economy, and, more generally, the situation
of Danone Spain. Some other minority shareholders opted not to continue the discussion process and
have since decided to submit this disagreement to the competent jurisdiction.

Danone is considering further share buybacks totaling between EUR100 and 200 millions within the
next few weeks. 

2013 Outlook (from press release dated February 19, 2013)

The Group assumes that trends in consumer demand will continue to show contrasts from region to
region, with overall trends negative in Europe-assuming, however, no major political or economic
upheavals-and favorable in the rest of the world. 

The Group also expects the cost of its major raw materials and packaging materials to remain high,
with moderate growth.

This being the case, the Group will continue to adapt its model in Europe, stepping up the pace of
updates to its product ranges in response to consumers' changing needs, and at the same time
adapting its structures and costs to achieve EUR200 million in savings by the end of 2014.

In the rest of the world, Danone will continue to expand its product categories, build its brands
and grow its market share in a profitable and lasting way. 

Through these actions, Danone plans to get back on track to strong, profitable organic growth as
of 2014.

For 2013, which will remain a year of transition, the Group has set the following targets:
·        like-for-like[2] sales[1] growth of at least +5%
·        a decline in trading operating margin, by between -50 bps and -30 bps like-for-like[2]
·        free cash-flow of around EUR2 billion excluding exceptional items[2]


[1] Net sales
[2] See page 7 for details on calculation of financial indicators not defined in IFRS

Key financial transactions and other developments during the quarter (from press releases issued
in Q1 2013)

On February 22, 2013, Danone finalized its acquisition of exclusive control (67.0%) of Centrale
Laitière (Morocco) by acquiring part of SNI's shareholding for a total EUR543 million.[1] Since
2001, the Group had held 29.2% of this company's capital. Having raised its shareholding in
Centrale Laitière above the 40% threshold, the Group was required to file a mandatory takeover bid
for the company's shares.


[1]6,050 million dirhams, equal to EUR543 million at an exchange rate of 11.15 dirhams/1 euro.

On February 27, 2013, Danone announced the successful launch of a EUR750 million bond issue
maturing June 6, 2018. The issue, priced at mid swap +33 basis points, pays a coupon of 1.25%, and
was widely subscribed by a broad investor base. Funds raised will enable Danone to diversify its
sources of finance and extend the maturity of its debt at favorable market conditions.

Our presentation to analysts and investors will be broadcast live at 9.00 am (Paris time) this
Tuesday, April 16, 2013. Slides will be available on our website (www.finance.danone.com) from
7.30 am (Paris time) today.





This press release contains certain forward-looking statements concerning Danone. Although Danone
believes its expectations are based on reasonable assumptions, these forward-looking statements
are subject to numerous risks and uncertainties, which could cause actual results to differ
materially from those anticipated in these forward-looking statements. For a more detailed
description of these risks and uncertainties, we invite you to refer to the Registration Document
("Risk Factors" section, available at www.danone.com http://www.danone.com/ ).
APPENDIX - Sales by division and by region

                           First quarter   
 EUR millions              2012     2013   
 BY BUSINESS LINE                          
 Fresh Dairy Products     2 960    2 952   
 Waters                    841      887    
 Baby Nutrition           1 014    1 177   
 Medical nutrition         302      322    
 BY GEOGRAPHICAL AREA                      
 Europe excl. CIS         2 116    2 005   
 CIS & North America[2]   1 084    1 163   
 ALMA[3]                  1 917    2 170   
 Group                    5 117    5 338   

                                 First quarter 2013          
 EUR millions            Reported change       Change        
 BY BUSINESS LINE                                            
 Fresh Dairy Products         -0.3%              0.7%        
 Waters                        5.5%              8.6%        
 Baby Nutrition               16.1%             17.1%        
 Medical nutrition             6.4%              6.3%        
 BY GEOGRAPHICAL AREA                                        
 Europe excl. CIS             -5.3%             -5.1%        
 CIS & North America[2]        7.4%              8.5%        
 ALMA[3]                      13.2%             16.6%        
 Group                        +4.3%             +5.6%        

[1] See page 7 for details on calculation of financial indicators not defined in IFRS
              [2] North America: United States and Canada
              [3] Asia-Pacific / Latin America / Middle East / Africa
Financial indicators not defined in IFRS

Information published by Danone uses the following financial indicators that are not defined by

*Like-for-like changes in net sales, trading operating income, trading operating margin and
underlying net income 
*Trading operating income 
*Trading operating margin 
*Underlying net income 
*Free cash-flow  
*Free cash-flow excluding exceptional items 

Given severe deterioration in consumer spending in Europe, Danone has set a target for savings and
adaptation of its organization to regain its competitive edge. Starting in the first half of 2013,
Danone will publish a free cash-flow indicator excluding cash-flows related to initiatives
deployed within the framework of this plan. In 2012, free cash-flow excluding exceptional items
was equal to free cash-flow and totaled EUR2,088 million.

To facilitate comparison with other companies, the Group has revised its definition of
like-for-like changes, aligning itself on market practice to measure the impact of changes in the
scope of consolidation. Starting in the first quarter of 2013, financial communications from
Danone incorporate this new indicator (see definition below). 

Financial indicators used by the Group and not defined in IFRS are calculated as follows:

Like-for-like changes in net sales, trading operating income, trading operating margin and net
income-Group share, essentially exclude the impact of: (i) changes in exchange rates, with both
previous year and current-year indicators calculated using the same exchange rates (the exchange
rate used is a projected annual rate determined by the Group for the current year and applied to
both years), and (ii) changes in consolidation scope, with indicators related to considered fiscal
year calculated on the basis of previous-year scope. 

Trading operating income and expense is defined as the Group operating income before other
operating income and expense. Other operating income and expense is defined under Recommendation
2009-R.03 of the French CNC, and comprises significant items that, because of their exceptional
nature, cannot be viewed as inherent to current (ordinary) activities. These mainly include
capital gains and losses on disposals of fully consolidated companies, impairment charges on
goodwill, significant costs related to strategic restructuring and major external growth
operations, and costs related to major litigation. Since application of IFRS 3 (Revised), other
income and operating expense have also included acquisition fees related to business combinations.

Trading operating margin is defined as the trading operating income over net sales ratio.

Free cash-flow represents cash flows provided or used by operating activities less capital
expenditure net of disposals and excluding acquisition costs related to business combinations
(since the application of IFRS 3 (Revised)).

Free cash flow excluding exceptional items represents free cash flow before cash flows related to
initiatives that may be taken by the Group to deploy the plan to generate savings and adapt
organization in Europe.

APPENDIX - Change in the definition of the regions and of the like-for-like changes: 
2012 and 2013 information, on the basis of new definitions

To adapt its reporting to trends in Group business, Danone has used a new geographical breakdown
to track operations since January 2013. To facilitate comparison with other companies, the Group
has revised its definition of like-for-like changes, aligning itself on market practice to measure
the impact of changes in the scope of consolidation. Based on these new definitions, data for the
first half of 2012 and 2013 is as follows:

          Sales                 Change         
     (EUR millions)        Like for like[1]    
    Q1 2012    Q1 2013    Q1 2012    Q1 2013   

 Europe excl. CIS      2 116  2 005   -0.5%  -5.1%  
 CIS & North America   1 084  1 163    5.3%   8.5%  
 ALMA                  1 917  2 170   18.1%  16.6%  
 Total                 5 117  5 338    6.9%   5.6%  

 Fresh Dairy Products   2 960  2 952    3.8%   0.7%  
 Waters                   841    887   16.4%   8.6%  
 Baby Nutrition         1 014  1 177    9.0%  17.1%  
 Medical Nutrition        302    322    6.4%   6.3%  
 Total                  5 117  5 338    6.9%   5.6%  

[1] Based on the revised definition of like-for-like changes - see page 7 for definition of
financial indicators not defined in IFRS 

For more information:
Press Relations : +33 1 44 35 20 75 - Investor Relations: +33 1 44 35 20 76
DANONE : 17, boulevard Haussmann, 75009 Paris

2013 First-Quarter Sales http://hugin.info/143411/R/1692778/556559.pdf 


This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.

The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the
information contained therein.

Source: DANONE via Thomson Reuters ONE